IDiyas

For the Inventor, By the Inventor

Shizuoka, Japan

Hiromi Nonaka

USPTO Granted Patents = 18

Average Co-Inventor Count = 7.9

ph-index = 8

Forward Citations = 174(Granted Patents)


Location History:

  • Shizuoka-ken, JP (1996 - 1997)
  • Sunto-gun, JP (1997 - 2000)
  • Shizuoka, JP (1991 - 2001)

Company Filing History:

goldMedal18 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents

Years Active: 1991-2001

Loading Chart...
18 patents (USPTO):Explore Patents
1. 6306847 - Condensed purine derivatives (2001-10-23),
2. 6222035 - [1,2,4] triazolo [1,5-C] pyrimidine derivatives (2001-04-24),
3. 6107064 - Process for producing xanthine derivatives with bacteria and fungi (2000-08-22),
4. 5948784 - Quinazoline derivatives (1999-09-07),
5. 5756735 - Xanthine derivatives (1998-05-26),
6. 5703085 - Xanthine derivatives (1997-12-30),
7. 5670498 - 8-substituted styryl xanthine derivatives (1997-09-23),
8. 5658917 - Isoquinolines having adenosine uptake inhibitor activity (1997-08-19),
9. 5648353 - Quinazolines and phthalazines having adenosine uptake inhibitor activity (1997-07-15),
10. 5624926 - Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors (1997-04-29),
11. 5605900 - Benzotriazines having adenosine uptake inhibitor activity (1997-02-25),
12. 5587378 - Therapeutic agent for Parkinson's disease (1996-12-24),
13. 5525607 - Xanthine compounds (1996-06-11),
14. 5484920 - Therapeutic agent for Parkinson's disease (1996-01-16),
15. 5395836 - 8-tricycloalkyl xanthine derivatives (1995-03-07),

Title: Hiromi Nonaka: Innovator in Pharmaceutical Chemistry

Introduction

Hiromi Nonaka is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 18 patents to his name, Nonaka's work has the potential to impact various medical conditions.

Latest Patents

Among his latest patents, Nonaka has developed condensed purine derivatives that exhibit adenosine A receptor antagonizing activity. These compounds demonstrate antiasthmatic and bronchodilator actions, as well as anti-itching effects. Another notable patent involves [1,2,4]Triazolo[1,5-c]pyrimidine derivatives, which are useful for treating or preventing diseases induced by hyperactivity of adenosine A receptors, such as Parkinson's disease and senile dementia.

Career Highlights

Hiromi Nonaka is currently employed at Kyowa Hakko Kogyo Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research focuses on creating effective treatments that address critical health issues, showcasing his dedication to improving patient outcomes.

Collaborations

Nonaka collaborates with esteemed colleagues, including Fumio Suzuki and Junichi Shimada, to advance their research initiatives. Their combined expertise fosters a productive environment for innovation and discovery.

Conclusion

Hiromi Nonaka's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also holds promise for improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…